Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar:97:53-60.
doi: 10.1016/j.maturitas.2016.12.003. Epub 2016 Dec 15.

Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis

Chee Kian Chew  1 , Bart L Clarke  2
Affiliations
Review

Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis

Chee Kian Chew et al. Maturitas. 2017 Mar.

Abstract

The treatment of osteoporosis is generally either by inhibition of bone resorption with antiresorptive agents or by stimulation of bone formation with anabolic agents. Currently, teriparatide (recombinant human parathyroid hormone 1-34 [rhPTH (1-34)]) is the only available approved anabolic agent in the U.S. Other anabolic agents are under investigation however. Abaloparatide is recombinant human parathyroid hormone-related peptide 1-34. This agent is an anabolic agent that appears more potent than teriparatide, and it may have more rapid onset of fracture reduction than teriparatide. It is currently undergoing FDA review, with approval expected in 2017.

Keywords: Abaloparatide; Anabolic agents; Fractures; Osteoporosis; PTHrP 1–34.

PubMed Disclaimer

MeSH terms

LinkOut - more resources